Neogen (NEOG) Revenue Growth (5y) (2015 - 2026)
Neogen (NEOG) Revenue Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn |
| 10 | Neogen | 2.06 Bn | 1.90 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 12.59% |
| Nov 30, 2025 | 14.33% |
| Aug 31, 2025 | 13.86% |
| May 31, 2025 | 15.63% |
| Feb 28, 2025 | 17.22% |
| Nov 30, 2024 | 16.49% |
| Aug 31, 2024 | 16.43% |
| May 31, 2024 | 16.62% |
| Feb 29, 2024 | 18.55% |
| Nov 30, 2023 | 16.48% |
| Aug 31, 2023 | 18.11% |
| May 31, 2023 | 17.47% |
| Feb 28, 2023 | 18.12% |
| Nov 30, 2022 | 17.97% |
| Aug 31, 2022 | 7.03% |
| May 31, 2022 | 7.22% |
| Feb 28, 2022 | 11.64% |
| Nov 30, 2021 | 56.83% |
| Aug 31, 2021 | 62.28% |
| May 31, 2021 | 7.18% |